Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Class A Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
65M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
12.8M
-
Shares change
-
+12.8M
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$105M
-
Number of buys
-
37
-
Number of sells
-
-2
-
Price
-
$8.20
Significant Holders of Zura Bio Ltd - Class A Ordinary Shares, $0.0001 par value (ZURA) as of Q2 2023
40 filings reported holding ZURA - Zura Bio Ltd - Class A Ordinary Shares, $0.0001 par value as of Q2 2023.
Zura Bio Ltd - Class A Ordinary Shares, $0.0001 par value (ZURA) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.8M shares
of 65M outstanding shares and own 19.76% of the company stock.
Largest 10 shareholders include GREAT POINT PARTNERS LLC (3.3M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.85M shares), Deep Track Capital, LP (2.52M shares), ARMISTICE CAPITAL, LLC (950K shares), CITADEL ADVISORS LLC (713K shares), Point72 Asset Management, L.P. (469K shares), BlackRock Inc. (406K shares), Monashee Investment Management LLC (240K shares), VANGUARD GROUP INC (228K shares), and GEODE CAPITAL MANAGEMENT, LLC (201K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.